Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Comparison of Continuous Performance Test Results of Former Morphine and Methamphetamine Users During the Early Abstinence Phase

Mehdi Tehrani-Doost 1 , Maryam Soleimannejad 2 , * , Anahita Khorrami 3 and Sadegh Yoosefee 4
Authors Information
1 Psychiatry Department, Medical School, Tehran University of Medical Sciences, Tehran, Iran
2 Psychiatry Department, Medical School, Qazvin University of Medical Sciences, Qazvin, Iran
3 Cognitive Neuroscience, Youtop Clinic, Tehran, Iran
4 Ph.D of Neuroscience, Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: September 2018, 12 (3); e57233
  • Published Online: September 4, 2018
  • Article Type: Original Article
  • Received: July 1, 2017
  • Revised: January 27, 2018
  • Accepted: April 15, 2018
  • DOI: 10.5812/ijpbs.57233

To Cite: Tehrani-Doost M , Soleimannejad M, Khorrami A, Yoosefee S. Comparison of Continuous Performance Test Results of Former Morphine and Methamphetamine Users During the Early Abstinence Phase, Iran J Psychiatry Behav Sci. 2018 ; 12(3):e57233. doi: 10.5812/ijpbs.57233.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:78-83. doi: 10.1016/j.ajp.2015.06.002. [PubMed: 26168763].
  • 2. Mehrjerdi ZA, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran. Int J STD AIDS. 2014;25(6):420-7. doi: 10.1177/0956462413512806. [PubMed: 24287028].
  • 3. Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country. Asian J Psychiatr. 2015;16:17-25. doi: 10.1016/j.ajp.2015.05.036. [PubMed: 26123235].
  • 4. Fishbein DH, Krupitsky E, Flannery BA, Langevin DJ, Bobashev G, Verbitskaya E, et al. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend. 2007;90(1):25-38. doi: 10.1016/j.drugalcdep.2007.02.015. [PubMed: 17382488]. [PubMed Central: PMC1991277].
  • 5. Al-Zahrani MA, Elsayed YA. The impacts of substance abuse and dependence on neuropsychological functions in a sample of patients from Saudi Arabia. Behav Brain Funct. 2009;5:48. doi: 10.1186/1744-9081-5-48. [PubMed: 20003358]. [PubMed Central: PMC2799426].
  • 6. Verdejo A, Toribio I, Orozco C, Puente KL, Perez-Garcia M. Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers. Drug Alcohol Depend. 2005;78(3):283-8. doi: 10.1016/j.drugalcdep.2004.11.006.
  • 7. Rogers RD, Robbins TW, Ron MA, Robbins TW. The neuropsychology of chronic drug abuse. In: Ron MA, Robbins TW, editors. Disorders of brain and mind. Cambridge: Cambridge University Press; 2003. p. 447-67. doi: 10.1017/cbo9780511550072.021.
  • 8. Dalley JW, Theobald DE, Berry D, Milstein JA, Laane K, Everitt BJ, et al. Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance. Neuropsychopharmacology. 2005;30(3):525-37. doi: 10.1038/sj.npp.1300590. [PubMed: 15508024].
  • 9. Levine AJ, Hardy DJ, Miller E, Castellon SA, Longshore D, Hinkin CH. The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol. 2006;28(1):29-42. doi: 10.1080/13803390490918066. [PubMed: 16448974].
  • 10. Forman SD, Dougherty GG, Casey BJ, Siegle GJ, Braver TS, Barch DM, et al. Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biol Psychiatry. 2004;55(5):531-7. doi: 10.1016/j.biopsych.2003.09.011. [PubMed: 15023582].
  • 11. Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ, et al. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology. 2000;23(2):113-26. doi: 10.1016/S0893-133X(00)00097-X. [PubMed: 10882838].
  • 12. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24(2):97-129. doi: 10.1016/S0893-133X(00)00195-0. [PubMed: 11120394].
  • 13. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology. 2004;47 Suppl 1:345-58. doi: 10.1016/j.neuropharm.2004.07.030. [PubMed: 15464149].
  • 14. Ersche KD, Clark L, London M, Robbins TW, Sahakian BJ. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology. 2006;31(5):1036-47. doi: 10.1038/sj.npp.1300889. [PubMed: 16160707]. [PubMed Central: PMC1867318].
  • 15. Soleimannejad M, Tehranidoost M, Khorrami A, Pishyareh E. Evaluation of attention bias towards emotional scenes in pure morphine and methamphetamine abusers at their early abstinence period in comparison with each other and healthy control, an eye tracking study. Basic Clin Neurosci. 2015;6(4):223-30. [PubMed: 26649160]. [PubMed Central: PMC4668869].
  • 16. Kellough JL, Beevers CG, Ellis AJ, Wells TT. Time course of selective attention in clinically depressed young adults: an eye tracking study. Behav Res Ther. 2008;46(11):1238-43. doi: 10.1016/j.brat.2008.07.004. [PubMed: 18760771]. [PubMed Central: PMC2584153].
  • 17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62. [PubMed: 14399272]. [PubMed Central: PMC495331].
  • 18. Kaviani H, Mousavi AS. [Psychological tests and interview]. Tehran: Sana; 2001. Persian.
  • 19. Conners CK, Staff MHS, Connelly V, Campbell S, MacLean M, Barnes J. Conners’ continuous performance test II (CPT II v. 5). North Tonawanda, New York: Multi-Health Syst Inc; 2000.
  • 20. Sandford JA, Turner A. Manual for the integrated visual and auditory continuous performance test. Richmond, VA: Braintrain; 1995.
  • 21. Gordon Systems. Technical manual for the Gordon Diagnostic System. DeWitt, NY; 1986.
  • 22. Conners CK. Multi health systems. Conners' continuous performance test II: Technical guide for software manual. New York: Multi-Health Systems; 2004.
  • 23. Cohen RA, O’Donnell BF. Attentional dysfunction associated with psychiatric illness. The neuropsychology of attention. New York: Plenum Press; 1993. p. 275-305. doi: 10.1007/978-1-4419-7463-1_12.
  • 24. Riccio CA, Reynolds CR, Lowe PA. Clinical applications of continuous performance tests: Measuring attention and impulsive responding in children and adults. John Wiley & Sons Inc; 2001.
  • 25. Price KL, DeSantis SM, Simpson AN, Tolliver BK, McRae-Clark AL, Saladin ME, et al. The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina. Am J Addict. 2011;20(5):447-55. doi: 10.1111/j.1521-0391.2011.00164.x. [PubMed: 21838844]. [PubMed Central: PMC3603567].
  • 26. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry. 2005;58(10):770-8. doi: 10.1016/j.biopsych.2005.04.039. [PubMed: 16095568].
  • 27. Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl). 2006;188(2):162-70. doi: 10.1007/s00213-006-0494-0. [PubMed: 16915378].
  • 28. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci. 2006;31(5):301-13. [PubMed: 16951733]. [PubMed Central: PMC1557685].
  • 29. Verdejo-Garcia A, Bechara A, Recknor EC, Perez-Garcia M. Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc. 2006;12(3):405-15. [PubMed: 16903133].
  • 30. Rapeli P, Kivisaari R, Autti T, Kahkonen S, Puuskari V, Jokela O, et al. Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry. 2006;6:9. doi: 10.1186/1471-244X-6-9. [PubMed: 16504127]. [PubMed Central: PMC1489929].
  • 31. Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest. 2003;111(10):1444-51. doi: 10.1172/JCI18533. [PubMed: 12750391]. [PubMed Central: PMC155054].
  • 32. Fein G, Di Sclafani V, Meyerhoff DJ. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend. 2002;68(1):87-93. [PubMed: 12167554]. [PubMed Central: PMC2857690].
  • 33. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage. 2003;19(3):1095-102. [PubMed: 12880835].
  • 34. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci. 2004;24(26):6028-36. doi: 10.1523/JNEUROSCI.0713-04.2004. [PubMed: 15229250].
  • 35. Danos P, Van Roos D, Kasper S, Bromel T, Broich K, Krappel C, et al. Enlarged cerebrospinal fluid spaces in opiate-dependent male patients: a stereological CT study. Neuropsychobiology. 1998;38(2):80-3. doi: 10.1159/000026521. [PubMed: 9732207].
  • 36. Pezawas LM, Fischer G, Diamant K, Schneider C, Schindler SD, Thurnher M, et al. Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements. Psychiatry Res. 1998;83(3):139-47. [PubMed: 9849723].
  • 37. Seiden LS, Sabol KE, Ricaurte GA. Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol. 1993;33:639-77. doi: 10.1146/ [PubMed: 8494354].
  • 38. De Vries TJ, Shippenberg TS. Neural systems underlying opiate addiction. J Neurosci. 2002;22(9):3321-5. [PubMed: 11978806].
  • 39. United Nations Office on Drugs and Crime . 2011 World Drug Report. New York: UNODC publications; 2011.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments